$26MSeries B, 12 May 2026
Funds expansion beyond cardiometabolic care into more high-cost chronic conditions.
- Amount
- $26M
- Stage
- Series B
- Announced
- 12 May 2026
- Lead
- Define Ventures
- Other investors
- SemperVirens VC, Catalio Capital Management, NewHealth Ventures, 7Wire Ventures, The Cigna Group Ventures
- Use of funds
- Funds expansion beyond cardiometabolic care into more high-cost chronic conditions.
- Checked
- Announced by the company
- Sources
- 9amHealth raises $26M Series B vcaonline.com
9amHealth raises $26M Series B pulse2.com